Research Article
Depression and Dementia in Patients with Parkinson’s Disease
Vashadze S1*, Brunjadze S1, Kekenadze M2, Qatamadze Sh3, Kvirkvelia N4 and Beridze M2
1Batumi Shota Rustaveli State University, Batumi, Georgia
2Tbilisi State Medical University, Tbilisi, Georgia
3Batumi Medcenter
4Tbilisi State University
*Corresponding author: Vashadze S, Batumi Shota Rustaveli State University, Batumi, Georgia; E-mail: dake58@mail.ru
Article Information: Submission: 26/05/2022; Accepted: 13/08/2022; Published: 18/08/2022
Copyright: © 2022 Vashadze S, et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Abstract
Introduction: Dementia is characterized by a decline in thinking, emotional flatness, and reasoning that develops in many people
living with Parkinson’s and begins at least a year after diagnosis [1,2]. The aim of our study was to determine the rate of depression and
cognitive impairment in patients with Parkinson’s disease in Georgia. We studied patients diagnosed with Parkinson’s disease 3-10 years
before our study began.
Methods: The study was conducted at a Medical Center in Batumi, Georgia in between 2018-2021. Written informed consent was
obtained from all subjects or their legal representatives before the study. None of the participants had another neurological, psychiatric,
ophthalmological, or musculoskeletal co morbidity that interfered with the research. Handedness was assessed using the Edinburgh
Handedness Inventory. The Beck depression scale (Beck depression inventory - BDI) was used to evaluate the severity of depression.
Neuroimaging was performed in all patients - computer tomography or magnetic resonance imaging (CT or MRI). Neuroimaging studies
were used to measure brain volume and extent of cortical atrophy in parkinsonian patients. For the diagnosis of dementia, Mini-Mental
State Examination was used.
Results: In patients with Parkinson’s disease, the middle age was 69.4 years. Moderate dementia was detected in 20 (20%) of
patients - a significant deterioration in memory for current events were seen. severe dementia was detected in 25 (25%) of patients
with Parkinson’s disease. Depressive disorders were detected in 82 persons (42 women and 40 men). Among them, 20% fulfilled signs
of a moderate degree of depression, 25% severe degree of depression, and 55% mild degree of depression. There was no correlation
between the onset time of disease and the severity of depression. Our neuroimaging studies revealed cortical atrophy in 24 (24%) of the
patients with the expansion of the ventricles. The atrophic process is strongly expressed in the temporal and frontal regions.
Conclusion: The incidence of cognitive impairment in patients with Parkinson’s disease was quite high in Georgia. According to our
study, patients with Parkinson’s disease have a fairly high rate of both depression and the degree of dementia. Depression and dementia
appear soon after the onset of the disease.
